Dermatomyositis Pathology

NewsGuard 100/100 Score

Dermatomyositis is an inflammatory disorder that primarily causes muscle weakness and a skin rash. As a systemic condition, dermatomyositis can also involve the lungs, joints, esophagus and sometimes the heart.

The exact cause of dermatomyositis is not clear, although the condition shares many similarities with autoimmune disorders. It is thought that autoantibodies may target the capillaries in muscles and disrupt the blood supply to muscles.

Dermatomyositis belongs to a class of disorders called the inflammatory myopathies and leads to muscle atrophy and muscle damage.

Some of the most important autoantibodies that have been detected in dermatomyositis include:

  • Anti-synthetase ( targets tRNA synthetase enzymes)
  • Antibodies against cytoplasmic enzymes, which catalyze the covalent binding of amino acids to tRNA
  • Anti-hystidil-tRNA synthetase autoantibodies
  • Anti-signal recognition particle antibodies
  • Anti-Mi-2 antibodies

Diagnosis

Dermatomyositis may be diagnosed based on signs and symptoms, but other tests that may be used to confirm a diagnosis include:

Muscle biopsy

A sample of muscle tissue is removed and sent for laboratory analysis. This test may reveal the presence of inflammatory cells around muscle capillaries. This sample can also be checked for the presence of abnormal proteins and enzyme deficiencies.

Skin biopsy

A skin biopsy sample can be used to rule out other disorders and confirm a diagnosis, which may eliminate the need for a muscle biopsy.

Electromyograph

A needle electrode is inserted into the muscle to test the electrical activity, which can be abnormal in muscle disease. Different muscles can be tested to confirm disease distribution.

Blood analysis

Blood tests are performed to check for raised muscle enzymes, which can indicate muscle damage. Specific autoantibodies associated with the different forms of dermatomyositis can also be detected, which can aid treatment decisions.

Further Reading

Last Updated: Jul 6, 2023

Dr. Ananya Mandal

Written by

Dr. Ananya Mandal

Dr. Ananya Mandal is a doctor by profession, lecturer by vocation and a medical writer by passion. She specialized in Clinical Pharmacology after her bachelor's (MBBS). For her, health communication is not just writing complicated reviews for professionals but making medical knowledge understandable and available to the general public as well.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Mandal, Ananya. (2023, July 06). Dermatomyositis Pathology. News-Medical. Retrieved on May 28, 2024 from https://www.news-medical.net/health/Dermatomyositis-Pathology.aspx.

  • MLA

    Mandal, Ananya. "Dermatomyositis Pathology". News-Medical. 28 May 2024. <https://www.news-medical.net/health/Dermatomyositis-Pathology.aspx>.

  • Chicago

    Mandal, Ananya. "Dermatomyositis Pathology". News-Medical. https://www.news-medical.net/health/Dermatomyositis-Pathology.aspx. (accessed May 28, 2024).

  • Harvard

    Mandal, Ananya. 2023. Dermatomyositis Pathology. News-Medical, viewed 28 May 2024, https://www.news-medical.net/health/Dermatomyositis-Pathology.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.